What is a positive sentinel lymph node in a breast cancer patient? A practical approach

Breast

Volumn 16, Issue 2, 2007, Pages 152-160

  Cserni, Gábor ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Breast cancer; Isolated tumour cells; Metastasis; Sentinel lymph node; TNM

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN;

ADJUVANT THERAPY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CYTODIAGNOSIS; DRUG RESPONSE; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 33947627152     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.07.004     Document Type: Review

References (65)

1. Merriam-Webster OnLine Dictionary 〈http://www.m-w.com/cgi-bin/dictionary?book=Dictionary&va=positive&x=13&y=15〉.
2. Cserni G. Axillary staging of breast cancer and the sentinel node. J Clin Pathol 53 (2000) 733-741
3. Cserni G., Amendoeira I., Apostolikas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57 (2004) 695-701
4. Giuliano A.E., Dale P.S., Turner R.R., Morton D.L., Evans S.W., and Krasne D.L. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222 (1995) 394-401
5. Cserni G., Amendoeira I., Apostolikas N., et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39 (2003) 1654-1667
6. Turner R.R., Ollila D.W., Stern S., and Giuliano A.E. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23 (1999) 263-267
7. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 52 (1999) 922-924
8. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 113 (2000) 351-354
9. Diaz L.K., Hunt K., Ames F., et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27 (2003) 385-389
10. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55 (2002) 926-931
11. Viale G., Maiorano E., Mazzarol G., et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92 (2001) 1378-1384
12. In: Sobin L.H., and Wittekind C. (Eds). UICC TNM Classification of malignant Tumours. sixth ed (2002), Wiley, New York
13. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer staging manual. sixth ed (2002), Springer, New York
14. Cserni G., Bianchi S., Vezzosi V., et al. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol 59 (2006) 518-522
15. Weaver D.L. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant?. Am J Surg Pathol 27 (2003) 842-845
16. Singletary S.E., Greene F.L., and Sobin L.H. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 98 (2003) 2740-2741
17. Schwartz G.F., Giuliano A.E., Veronesi U., and Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94 (2002) 2542-2551
18. Colleoni M., Rotmensz N., Peruzzotti G., et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23 (2005) 1379-1389
19. Dowlatshahi K., Fan M., Snider H.C., and Habib F.A. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80 (1997) 1188-1197
20. Kuijt G.P., Voogd A.C., van de Poll-Franse L.V., Scheijmans L.J., van Beek M.W., and Roumen R.M. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 31 (2005) 500-505
21. Degnim A.C., Griffith K.A., Sabel M.S., et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98 (2003) 2307-2315
22. Schrenk P., Konstantiniuk P., Wolfl S., et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br J Surg 92 (2005) 707-713
23. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 (2004) 1245-1252
24. Viale G., Maiorano E., Pruneri G., et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241 (2005) 319-325
25. Cserni G. Further axillary metastases associated with isolated tumor cells in sentinel lymph nodes of breast cancer patients. Ann Surg 243 (2006) 287
26. Calhoun K.E., Hansen N.M., Turner R.R., and Giuliano A.E. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190 (2005) 588-591
27. Hermanek P., Hutter R.V., Sobin L.H., and Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86 (1999) 2668-2673
28. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335 (1990) 1565-1568
29. Roberts C.A., Beitsch P.D., Litz C.E., et al. Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg 186 (2003) 324-329
30. Weaver D.L., Krag D.N., Manna E.A., Ashikaga T., Harlow S.P., and Bauer K.D. Comparison of pathologist-detected and automated computer-assisted image analysis detected sentinel lymph node micrometastases in breast cancer. Mod Pathol 16 (2003) 1159-1163
31. Mesker W.E., Torrenga H., Sloos W.C., et al. Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer. J Clin Pathol 57 (2004) 960-964
32. Weaver D.L., Krag D.N., Manna E.A., et al. Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer: an NSABP Protocol B-32 Quality Assurance Study. Cancer 107 (2006) 661-667
33. Cserni G., Bianchi S., Boecker W., et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103 (2005) 358-367
34. Cserni G., Sapino A., and Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 15 (2005) 347-354
35. Maiorano E., Mazzarol G.M., Pruneri G., et al. Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 27 (2003) 513-518
36. Franke W.W., and Moll R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation 36 (1987) 145-163
37. Xu X., Roberts S.A., Pasha T.L., and Zhang P.J. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 124 (2000) 1310-1313
38. Carter B.A., Jensen R.A., Simpson J.F., and Page D.L. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 113 (2000) 259-265
39. Diaz L.K., Wiley E.L., and Venta L.A. Are malignant cells displaced by large-gauge needle core biopsy of the breast?. Am J Roentgenol 173 (1999) 1303-1313
40. Diaz N.M., Vrcel V., Centeno B.A., and Muro-Cacho C. Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes. Adv Anat Pathol 12 (2005) 7-9
41. Diaz N.M., Mayes J.R., and Vrcel V. Breast epithelial cells in dermal angiolymphatic spaces: a manifestation of benign mechanical transport. Hum Pathol 36 (2005) 310-313
42. Bleiweiss I.J., Nagi C.S., and Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24 (2006) 2013-2018
43. King T.A., Ganaraj A., Fey J.V., et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. Cancer 101 (2004) 926-933
44. Peters-Engl C., Konstantiniuk P., Tausch C., et al. The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group. Br J Cancer 91 (2004) 1782-1786
45. Moore K.H., Thaler H.T., Tan L.K., Borgen P.I., and Cody III H.S. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?. Cancer 100 (2004) 929-934
46. Hansen N.M., Ye X., Grube B.J., and Giuliano A.E. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 139 (2004) 634-640
47. Diaz N.M., Cox C.E., Ebert M., et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol 28 (2004) 1641-1645
48. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23 (2005) 2694-2702
49. Xing Y., Foy M., Cox D.D., Kuerer H.M., Hunt K.K., and Cormier J.N. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93 (2006) 539-546
50. Jones J.L., Zabicki K., Christian R.L., et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 190 (2005) 517-520
51. Deurloo E.E., Tanis P.J., Gilhuijs K.G., et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39 (2003) 1068-1073
52. Sapino A., Cassoni P., Zanon E., et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 88 (2003) 702-706
53. Lemos S., Dias M., Goncalo M., Pinto E., Fernandes G., and Oliveira C. Detection of axillary metastases in breast cancer patients using ultrasound and colour Doppler combined with fine needle aspiration cytology. Eur J Gynaecol Oncol 26 (2005) 165-166
54. Pogacnik A., Klopcic U., Grazio-Frkovic S., Zgajnar J., Hocevar M., and Vidergar-Kralj B. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Cytopathology 16 (2005) 71-76
55. Tew K., Irwig L., Matthews A., Crowe P., and Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92 (2005) 1068-1080
56. Cserni G. Axillary staging of breast cancer and the sentinel node. J Clin Pathol 53 (2000) 733-741
57. Leers M.P., Schoffelen R.H., Hoop J.G., et al. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol 55 (2002) 359-366
58. Gillanders W.E., Mikhitarian K., Hebert R., et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 239 (2004) 828-837
59. Weigelt B., Verduijn P., Bosma A.J., Rutgers E.J., Peterse H.L., and van't Veer L.J. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 90 (2004) 1531-1537
60. Hughes S.J., Xi L., Raja S., Gooding W., Cole D.J., Gillanders W.E., et al. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg 243 (2006) 389-398
61. Greene F.L. TNM: our language of cancer. CA Cancer J Clin 54 (2004) 129-130
62. Houvenaeghel G., Nos C., Mignotte H., et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24 (2006) 1814-1822
63. Klevesath M.B., Bobrow L.G., Pinder S.E., and Purushotham A.D. The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. Br J Cancer 92 (2005) 2201-2205
64. Viale G., Mastropasqua M.G., Maiorano E., and Mazzarol G. Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch 448 (2006) 241-247
65. In: Perry N., Broeders M., and de Wolf C. (Eds). European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. fourth ed (2006), European Communities, Luxemburg